The 2026–27 Federal Budget, delivered on 12 May, continued the Government’s focus on improving affordability and access to healthcare, with significant investment in the Pharmaceutical Benefits Scheme (PBS), public hospitals and broader system reform.
SHPA today welcomes new Federal Government legislation to further mitigate the impact of medicines shortages on Australians and ensure new and innovative medicines are accessible, available and affordable for all Australians into the future.
Our expert understanding of the multiple funding and regulatory frameworks with respect to medicines.
